| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 05/10/2002 | WO2001027135A3 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 05/10/2002 | WO2001023389A3 Certain alkylene diamine-substituted heterocycles |
| 05/10/2002 | WO2001002000A3 Method and composition for affecting reproductive systems |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | WO2000050639A3 Gene sequence variations with utility in determining the treatment of disease |
| 05/10/2002 | CA2427952A1 Dna expression vectors |
| 05/10/2002 | CA2427731A1 Gnrh analogues for treatment of urinary incontinence |
| 05/10/2002 | CA2427613A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 05/10/2002 | CA2427533A1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 05/10/2002 | CA2426762A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors |
| 05/09/2002 | US20020055632 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction |
| 05/09/2002 | US20020055526 Modulators of SKCa, IKCa and BKCa channels. |
| 05/09/2002 | US20020054880 Suppressing inflammatory response in mammal by the administration of lectin derived carbohydrate binding peptide capable of binding terminally linked alpha-sialic acid derivative |
| 05/08/2002 | EP1203770A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases |
| 05/08/2002 | EP1203081A2 Human intracellular signaling molecules |
| 05/08/2002 | EP1203015A2 Human chaperone proteins |
| 05/08/2002 | EP1203011A1 Orally active androgens |
| 05/08/2002 | EP1203007A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1202994A1 New compounds |
| 05/08/2002 | EP1202991A1 Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation |
| 05/08/2002 | EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 05/08/2002 | EP1202980A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 05/08/2002 | EP1202966A1 Piperidine alcohols |
| 05/08/2002 | EP1202738A1 Dihydropyrazine derivatives as npy antagonists |
| 05/08/2002 | EP1202725A1 Method of treating symptoms of hormonal variation, including hot flashes |
| 05/08/2002 | EP1202630A1 Natural, anti-bacterial, anti-inflammation, anti-virus, anti-herpes cream |
| 05/08/2002 | EP1202620A1 Anti-inflammatory therapy for inflammatory mediated infection |
| 05/08/2002 | EP0839052B1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
| 05/08/2002 | CN1348465A Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 05/08/2002 | CN1348454A Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 05/08/2002 | CN1348383A Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
| 05/08/2002 | CN1348378A Method of promoting cervical and vaginal secretions |
| 05/08/2002 | CN1347718A Chinese medicine for treating women's genital system diseases |
| 05/08/2002 | CN1347716A Medicine bolus for recuperating from mastopathy |
| 05/08/2002 | CN1347702A Mixed live bacillus drops of bifidobacterium and lactobacillaceau and its prepn |
| 05/07/2002 | US6384281 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 05/07/2002 | US6384261 Treating endothelin-mediated disorders; inhibitory binding of endothilin peptides to eta and/or etb receptors; elucidating the physiological and pathophysiological roles and isolating endothelin receptors; antagonists |
| 05/07/2002 | US6384225 Intermediates in the preparation of substituted chroman derivatives |
| 05/07/2002 | US6384080 Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase |
| 05/07/2002 | US6384070 Restenosis, kidney diseases, lung diseases |
| 05/07/2002 | US6383780 2786, a novel human aminopeptidase |
| 05/02/2002 | WO2002035235A2 Net as regulator of angiogenic expression |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034767A1 Vegf peptides and their use for inhibiting angiogenesis |
| 05/02/2002 | WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034747A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 05/02/2002 | WO2002034741A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
| 05/02/2002 | WO2002034726A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034286A1 Methods for treating endocrine disorders |
| 05/02/2002 | WO2002012537A3 Mutant trichosanthin |
| 05/02/2002 | WO2001087316A3 Composition and method for increasing testosterone levels |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001074840A3 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 05/02/2002 | WO2001072778A3 Method of identifying inhibitors of tie-2 |
| 05/02/2002 | WO2001061008A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001060162A3 Cationic, amphipathic beta-sheet peptides and uses thereof |
| 05/02/2002 | WO2001046394A3 Mammalian protein phosphatases |
| 05/02/2002 | WO2001036979A3 Placental human neurokinin b precursor |
| 05/02/2002 | WO2001009121A3 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 05/02/2002 | WO2000059491A3 Methods for modulating the human sexual response |
| 05/02/2002 | WO2000044395A9 Methods and compositions for modulating fertility |
| 05/02/2002 | US20020052495 Pyramidine or triazine derivatives which specifically inhibit the binding of endothelin to the receptor |
| 05/02/2002 | US20020052443 Non-antigenic branched polymer conjugates |
| 05/02/2002 | US20020052404 Compositions and methods for treating or preventing diseases of body passageways |
| 05/02/2002 | US20020052400 Substituted O- and/or S heterocyclic compounds; powerful ligands for melatoninergic receptors. |
| 05/02/2002 | US20020052397 Treatment of diseases characterized by excess Th2 cytokines and/ or an excess IgE production. |
| 05/02/2002 | US20020052387 5-Substituted 2-aryl-4-pyrimidinones |
| 05/02/2002 | US20020052383 Phenylcycloalkylmethylamino and phenylalkenylamino derivatives, including 1-phenyl-2-aminomethylcyclopropanes; treatment of a variety of metabolic, feeding, and sexual disorders including obesity. |
| 05/02/2002 | US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder |
| 05/02/2002 | US20020052352 Treating a malignant tumor, like a melanoma, using plant-derived compounds |
| 05/02/2002 | US20020052341 Bupropion metabolites and methods of their synthesis and use |
| 05/02/2002 | US20020052340 Treating disorders ameliorated by inhibition of neuronal monoamine reuptake, such as erectile dysfunction, affective disorders, cerebral function disorders, cigarette smoking, and incontinence. |
| 05/02/2002 | US20020052337 Composition and method for inhibiting platelet aggregation |
| 05/02/2002 | US20020052320 Sustained peptide-release formulation |
| 05/02/2002 | US20020051771 Apoptotic entities for use in treatment of T-cell-mediated and inflammatory disorders |
| 05/02/2002 | EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |
| 05/02/2002 | EP1201243A1 Use of sulfadiazine and sulfadimidine for treating erectile dysfunction |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | EP1200579A2 Antisense therapy for hormone-regulated tumors |
| 05/02/2002 | EP1200560A1 Melanin-concentrating hormone receptor |
| 05/02/2002 | EP1200477A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 05/02/2002 | EP1200472A1 Odorant receptors |
| 05/02/2002 | EP1200447A1 Oxazinocarbazoles for the treatment of cns diseases |
| 05/02/2002 | EP1200446A1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
| 05/02/2002 | EP1200445A1 Thienopyranecarboxamide derivatives |
| 05/02/2002 | EP1200422A2 Pyrazole compositions useful as inhibitors of erk |
| 05/02/2002 | EP1200419A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 05/02/2002 | EP1200402A1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 05/02/2002 | EP1200400A1 Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists |
| 05/02/2002 | EP1200151A1 Drug delivery device for insertion into the vagina, rectum or nasal cavity |
| 05/02/2002 | EP1200107A2 Composition having steroidal estrogen effect without increasing the risk of breast cancer |
| 05/02/2002 | EP1200092A2 Beta-carboline drug products |
| 05/02/2002 | EP1200091A1 Beta-carboline pharmaceutical compositions |
| 05/02/2002 | EP1200090A1 Beta-carboline pharmaceutical compositions |
| 05/02/2002 | EP0846118B1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 05/02/2002 | DE10050831A1 Verfahren zum Zyklusstart bei weiblichen Zuchttieren A method for cycle start at breeding ewes |
| 05/02/2002 | DE10049483A1 Substituierte 1-Aminobutan-3-ol-Derivate Substituted 1-aminobutan-3-ol derivatives |